Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized ascending-dose study of oral moxidectin in microfilaremic loiasis
PACTR202303704849277Phase 2Recruiting
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Apr 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of moxidectin in loiasis, sponsored by Bernhard Nocht Institute for Tropical Medicine. Started Apr 2023; status: recruiting.
02
Drugs
moxidectin
03
Conditions
loiasis
Beyond the preview
Go deeper on PACTR202303704849277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303704849277.